Miraiku overview:
[I would like to talk to someone who has had the same illness or experience as me. ]
When I got sick, I suddenly felt like I was left alone.
What should I tell the company? I find it difficult to talk about my illness even to friends. At the hospital, I didn't know what to ask, so I just said, "I'm fine." But I'd like to ask someone. I want you to listen.
[I want to share experiences and information with various people. ]
I was worried about whether the treatment was really suitable for me and whether there were any other options, so I spent the night researching it online.
What I found was a connection with patients. Since we were patients, there were things we could hear and talk about.
It gave me courage to know that I wasn't alone. I feel that if I take one step forward, the world will change.
[Right now, I hope that my experience will be helpful to someone. ]
At that time, I could only ask doctors and nurses about medicines and treatments, but sometimes we can understand how we feel about illness because we are fellow patients.
We hope that our voices will one day lead to new treatments and medicines, and lead to our future.
We, Buzzreach Co., Ltd.
With the vision of "creating a platform that connects all people, centered on patients," we are a company that uses technology to support clinical trials and clinical research conducted by pharmaceutical companies to develop new drugs.
In order to realize ``patient-centricity'' in drug development that incorporates the voices of patients, we must lower the barriers as much as possible between those who create better treatments, such as pharmaceutical companies and researchers, and the patients. It is necessary.
Through Miraiku, we will create a system that will deliver the voices of patients to pharmaceutical companies and researchers, and will connect patients' voices to drug discovery, early approval of new drugs, and the establishment of new treatments. We will continue to work hard to provide treatment options for patients fighting the disease.
In developing Miraiku, we received cooperation from many people, including patient associations.
We hope that through Miraiku's patient support network, patients who have previously had difficulty connecting with each other will be able to connect with each other and share their concerns and wisdom more easily.
In the future, we plan to participate in "Patient and Public Involvement (PPI)" promoted by national institutions as part of the medical research and clinical trial process.
As part of our support for pharmaceutical companies' clinical trials and research, we also operate a "clinical trial matching site" for patients.
[I would like to talk to someone who has had the same illness or experience as me. ]
When I got sick, I suddenly felt like I was left alone.
What should I tell the company? I find it difficult to talk about my illness even to friends. At the hospital, I didn't know what to ask, so I just said, "I'm fine." But I'd like to ask someone. I want you to listen.
[I want to share experiences and information with various people. ]
I was worried about whether the treatment was really suitable for me and whether there were any other options, so I spent the night researching it online.
What I found was a connection with patients. Since we were patients, there were things we could hear and talk about.
It gave me courage to know that I wasn't alone. I feel that if I take one step forward, the world will change.
[Right now, I hope that my experience will be helpful to someone. ]
At that time, I could only ask doctors and nurses about medicines and treatments, but sometimes we can understand how we feel about illness because we are fellow patients.
We hope that our voices will one day lead to new treatments and medicines, and lead to our future.
We, Buzzreach Co., Ltd.
With the vision of "creating a platform that connects all people, centered on patients," we are a company that uses technology to support clinical trials and clinical research conducted by pharmaceutical companies to develop new drugs.
In order to realize ``patient-centricity'' in drug development that incorporates the voices of patients, we must lower the barriers as much as possible between those who create better treatments, such as pharmaceutical companies and researchers, and the patients. It is necessary.
Through Miraiku, we will create a system that will deliver the voices of patients to pharmaceutical companies and researchers, and will connect patients' voices to drug discovery, early approval of new drugs, and the establishment of new treatments. We will continue to work hard to provide treatment options for patients fighting the disease.
In developing Miraiku, we received cooperation from many people, including patient associations.
We hope that through Miraiku's patient support network, patients who have previously had difficulty connecting with each other will be able to connect with each other and share their concerns and wisdom more easily.
In the future, we plan to participate in "Patient and Public Involvement (PPI)" promoted by national institutions as part of the medical research and clinical trial process.
As part of our support for pharmaceutical companies' clinical trials and research, we also operate a "clinical trial matching site" for patients.
Show More
